Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Parkman Healthcare Partners LLC
Form 13F · Q2 2026

Parkman Healthcare Partners LLC

CIK 1777015申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$9.8亿
申报组合市值
77
持仓数量
12
Quarters on record
Top 50
持仓数量

Parkman Healthcare Partners LLC——持仓

共 77 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1MBX Mbx Biosciences Inc800,173+0.0%$4417万4.5%
2LLY Eli Lilly & Co35,000+1.1%$4198万4.3%
3CVS Cvs Health Corp391,791+1.2%$4053万4.1%
4DXCM Dexcom Inc534,767−22.5%$3602万3.7%
5PTCT Ptc Therapeutics Inc435,691+1.0%$3554万3.6%
6RCUS Arcus Biosciences Inc919,266−23.9%$2834万2.9%
7GPCR Structure Therapeutics Inc485,661+109.3%$2607万2.7%
8VRDN Viridian Therapeutics Inc1.4M+146.9%$2531万2.6%
9AGIO Agios Pharmaceuticals Inc669,046+65.8%$2483万2.5%
10INBX Inhibrx Biosciences Inc256,950—$2435万2.5%
11XENE Xenon Pharmaceuticals Inc397,379−20.1%$2399万2.5%
12EWTX Edgewise Therapeutics Inc577,036+78.7%$2344万2.4%
13UNH Unitedhealth Group Inc55,921—$2324万2.4%
14SYK Stryker Corporation67,973−56.1%$2140万2.2%
15IQV Iqvia Hldgs Inc105,811+22.0%$2044万2.1%
16ZBH Zimmer Biomet Holdings Inc232,557−13.7%$2002万2.0%
17PODD Insulet Corp131,378−16.1%$2000万2.0%
18ASMB Assembly Biosciences Inc721,181+75.4%$1982万2.0%
19SNDX Syndax Pharmaceuticals Inc877,256−2.7%$1918万2.0%
20EYPT Eyepoint Inc1.3M−4.9%$1842万1.9%
21THC Tenet Healthcare Corp97,280+94.1%$1820万1.9%
22LIVN Livanova Plc210,529−47.9%$1731万1.8%
23ANIP Ani Pharmaceuticals Inc202,907−27.7%$1680万1.7%
24BCRX Biocryst Pharmaceuticals Inc1.6M−4.9%$1624万1.7%
25ALNY Alnylam Pharmaceuticals Inc50,672+88.3%$1525万1.6%
26INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc364,269—$1495万1.5%
27NVST Envista Holdings Corporation553,916−22.2%$1460万1.5%
28DRUG Bright Minds Biosciences Inc205,053+411.4%$1439万1.5%
29XERS Xeris Biopharma Holdings Inc1.8M+5.0%$1432万1.5%
30AVTX Avalo Therapeutics Inc766,290—$1416万1.4%
31FDMT 4D Molecular Therapeutics In948,184+81.4%$1261万1.3%
32IMNM Immunome Inc594,202+47.3%$1259万1.3%
33STOK Stoke Therapeutics Inc355,443+5.6%$1163万1.2%
34WAT Waters Corp30,206+14.2%$1133万1.2%
35ANRO Alto Neuroscience Inc429,035—$1132万1.2%
36ORKA Oruka Therapeutics Inc113,188—$1077万1.1%
37ADPT Adaptive Biotechnologies Cor486,984−11.7%$1045万1.1%
38ABSI Absci Corporation894,374−52.0%$1037万1.1%
39MLYS Mineralys Therapeutics Inc380,354+0.1%$1026万1.1%
40COGT Cogent Biosciences Inc253,365+153.0%$981万1.0%
41QURE Uniqure Nv208,170+0.6%$959万1.0%
42TARS Tarsus Pharmaceuticals Inc150,000—$944万1.0%
43AMRX Amneal Pharmaceuticals Inc541,190+79.9%$937万1.0%
44IRTC Irhythm Holdings Inc67,267+67.6%$800万0.8%
45CYRX Cryoport Inc508,324—$798万0.8%
46BSX Boston Scientific Corp180,481−59.8%$770万0.8%
47CLYM Climb Bio Inc563,484—$735万0.8%
48AMLX Amylyx Pharmaceuticals Inc398,782−35.8%$716万0.7%
49UPB Upstream Bio Inc935,247+18.9%$647万0.7%
50RMD Resmed Inc32,983—$643万0.7%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。